Astrazeneca (AZN) Non-cash Items (2009 - 2026)
Astrazeneca (AZN) posted quarterly Non-cash Items of $7.5 billion for Q1 2026, up 44.31% year-over-year from $5.2 billion in Q1 2025, and up 415.45% quarter-over-quarter from -$2.4 billion in Q4 2025.
Astrazeneca (AZN) Non-cash Items (2009 - 2026) Analysis & Trends
Astrazeneca's Non-cash Items history runs 17 years deep, the most recent figure standing at $7.5 billion for Q1 2026.
- In Q1 2026, Non-cash Items rose 44.31% year-over-year to $7.5 billion; the TTM figure through Mar 2026 stood at $8.0 billion (up 171.91% YoY), while the FY2025 annual figure was $5.7 billion, up 4.95% from the prior year.
- Non-cash Items for Q1 2026 stood at $7.5 billion, up from -$2.4 billion in the prior quarter.
- The five-year high for Non-cash Items was $7.7 billion in Q1 2024, with the low at -$3.1 billion in Q3 2024.
- The 5-year median for Non-cash Items is $994.0 million (2024), against an average of $2.4 billion.
- Peak annual rise in Non-cash Items reached 2121.89% in 2025, while the deepest fall reached 339.64% in 2025.
- Astrazeneca's Non-cash Items stood at $519.0 million in 2022, then rose by 9.25% to $567.0 million in 2023, then soared by 75.31% to $994.0 million in 2024, then plunged by 339.64% to -$2.4 billion in 2025, then soared by 415.45% to $7.5 billion in 2026.
- Business Quant data shows AZN's Non-cash Items at $7.5 billion in Q1 2026, -$2.4 billion in Q4 2025, and -$1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.51 Bn |
| Mar 31, 2026 | 7.51 Bn |
| Dec 31, 2025 | -2.38 Bn |
| Dec 31, 2025 | -2.38 Bn |
| Sep 30, 2025 | -1.19 Bn |
| Sep 30, 2025 | -1.19 Bn |
| Jun 30, 2025 | 4.06 Bn |
| Jun 30, 2025 | 4.06 Bn |
| Mar 31, 2025 | 5.21 Bn |
| Mar 31, 2025 | 5.21 Bn |
| Dec 31, 2024 | 994.00 Mn |
| Dec 31, 2024 | 994.00 Mn |
| Sep 30, 2024 | -3.06 Bn |
| Sep 30, 2024 | -3.06 Bn |
| Jun 30, 2024 | -201.00 Mn |
| Jun 30, 2024 | -201.00 Mn |
| Mar 31, 2024 | 7.69 Bn |
| Mar 31, 2024 | 7.69 Bn |
| Jun 30, 2023 | 567.00 Mn |
| Jun 30, 2023 | 567.00 Mn |